abiraterone mylan
mylan ireland limited - abiraterono acetatas - prostatos navikai - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abiraterono acetatas - prostatos navikai - endokrininė terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
dasatinib accord
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukemija, mieloidas - antinavikiniai vaistai - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
smog (hyper, maxi, midi, mini)
pelgar international ltd, unit 13, newman lane, alton, hampshire, gu34 2qr (jungtinė karalystė). - permetrinas - veikliosios medžiagos cas nr.: 52645-53-1, eb nr.: 258-067-9, veikliosios medžiagos pavadinimas: permetrinas, koncentracija: 13.25% , veiklioji - insekticidai, akaricidai ir kitų nariuotakojų kontrolės produktai
prokum pasta
pelgar international limited, unit 13, newman lane, alton, hants, uk-gu34 2qr jungtinė karalystė. - brodifakumas - veikliosios medžiagos cas nr.: 56073-10-0, eb nr.: 259-980-5, veikliosios medžiagos pavadinimas: brodifakumas, koncentracija: 0.005% , veiklioji - rodenticidai
mauzer pasta, rodex pasta
pelgar international limited, unit 13, newman lane, alton, hants, gu34 2qr (jungtinė karalystė). - bromadiolonas - veikliosios medžiagos cas nr.: 28772-56-7, eb nr.: 249-205-9, veikliosios medžiagos pavadinimas: bromadiolonas, koncentracija: 0% , veiklioji - rodenticidai
mauzer, rodex whole wheat
pelgar international limited, unit 13, newman lane, alton, hants, gu34 2qr (jungtinė karalystė). - bromadiolonas - veikliosios medžiagos cas nr.: 28772-56-7, eb nr.: 249-205-9, veikliosios medžiagos pavadinimas: bromadiolonas, koncentracija: 0.0025% , veiklioji - rodenticidai
mumia
pelgar international limited, unit 13, newman lane, alton, hants, gu34 2qr (jungtinė karalystė). - difenakumas - veikliosios medžiagos cas nr.: 56073-07-5, eb nr.: 259-978-4, veikliosios medžiagos pavadinimas: difenakumas, koncentracija: 0.0025% , veiklioji - rodenticidai
mumia pasta
pelgar international limited, unit 13, newman lane, alton, hants, gu34 2qr (jungtinė karalystė) - difenakumas - veikliosios medžiagos cas nr.: 56073-07-5, eb nr.: 259-978-4, veikliosios medžiagos pavadinimas: difenakumas, koncentracija: 0.0025% , veiklioji - rodenticidai